Metabolic Pathways Library
Every article, presentation, spotlight, and news item we've tagged to Metabolic Pathways.
Showing 1–24 of 148
Methionine Restriction Triggers Autophagy Through Epigenetic Control
Methionine restriction extends lifespan in yeast by reducing S-adenosylmethionine production, which prevents methylation of protein phosphatase 2A and triggers sustained autophagy. Early-stage methionine restriction appears sufficient to activate this longevity pathway, suggesting a potential therapeutic target for human healthspan extension without sustained dietary restriction.
PI3K Structure Decouples Aging From Growth Control
Precise structural modifications to PI3K reveal that single amino acid changes can decouple lifespan, growth, and developmental timing through distinct signaling pathways. A gain-of-function mutation accelerates aging, while disruption of the Ras-binding interface extends growth and delays reproductive entry—demonstrating that PI3K outputs are context-dependent rather than monolithic.
AMPK Activation Restores Metabolic Efficiency in Human Trial
Cambrian Bio's ATX-304 demonstrated in Phase 1b trials the ability to activate AMPK, a cellular energy regulator that declines with age. Participants showed improvements in liver fat, visceral adiposity, triglycerides, and resting metabolic rate without safety concerns—validating a mechanism long pursued in longevity research.
How a Sirtuin Protects Against Brain Diseases
SIRT6, a sirtuin protein, protects against neurodegenerative diseases by maintaining nucleolar function and constraining protein synthesis, preventing the accumulation of misfolded proteins that drives age-related brain pathology. This mechanism represents a direct intervention point in proteostasis failure, a primary driver of cognitive decline.
Could PGC-1α hold the key to longevity?
PGC-1α, a transcriptional coactivator that regulates cellular energy metabolism and mitochondrial biogenesis, is emerging as a target for age-related disease intervention. Endurance Bio is advancing a small molecule (T-168) designed to upregulate PGC-1α, with Phase 2 trials underway in Parkinson's disease and potential applications across neurodegeneration, metabolic dysfunction, and frailty.
Sirtuin-FOXO Axis Sustains Mitochondrial Repair and Lifespan
Age-related decline in the sirtuin AcSirt2 impairs mitochondrial quality control in honey bees, while restoring this protein activates a FOXO-dependent pathway that clears damaged mitochondria, reduces oxidative stress, and extends lifespan. This mechanism identifies a conserved axis for mitochondrial homeostasis relevant to aging across species.
SIRT6 Regulates Protein Synthesis and Folding Through Nucleolar Remodeling
SIRT6 maintains proteostasis by suppressing ribosomal gene expression and translation rates through nucleolar control. Without functional SIRT6, excessive protein synthesis overwhelms the folding machinery, leading to protein aggregation and accelerated neurodegeneration in aging models.
Longevity Research July 2026: Mechanisms Advance, Clinical Translation Lags
July 2026 research advances span intermittent fasting, calcium homeostasis, thymic regeneration, and senolytic therapies in animal models, alongside policy discussions on physical activity guidelines and cautionary evidence from a fatal NAD⁺ infusion. The month illustrates both the promise and peril of experimental longevity interventions—mechanistic progress tempered by real-world safety failures and the gap between animal findings and clinical application.
Targeting an Appetite Hormone Receptor for Stronger Muscles
Suppressing the ghrelin receptor (GHSR-1a) improves muscle function and reduces sarcopenia in aging mice through enhanced mitochondrial efficiency and altered muscle fiber composition. Pharmacological inhibition of this receptor produced similar benefits in older mice, suggesting a translatable approach to sarcopenia without extending lifespan.
Valine Restriction Extends Male Lifespan in Mice
Dietary restriction of valine, a branched-chain amino acid, extends lifespan in male mice and improves healthspan markers in both sexes. The sex-specific lifespan benefit suggests that amino acid metabolism operates through distinct physiological pathways between males and females, with implications for precision nutritional interventions in aging.
SIRT6 centenarian variant activates cellular aging pathways
Genflow Biosciences is advancing SIRT6 gene therapy targeting age-related disease and metabolic dysfunction, with preclinical validation in aged dogs and planned human trials. SIRT6 activation represents a direct intervention in cellular aging pathways known to regulate energy metabolism, stress response, and tissue regeneration.
Ghrelin Receptor Deletion or Pharmacological Inhibition Improves Muscle Function in Aging Male Mice
Blocking the ghrelin receptor improves muscle endurance and mitochondrial function in aging mice without affecting muscle mass or lifespan. Both genetic deletion and pharmacological inhibition restore markers of mitochondrial renewal, suggesting this pathway is a viable therapeutic target for age-related muscle decline.
Targeting an Appetite Hormone Receptor for Stronger Muscles
Inhibiting the ghrelin receptor (GHSR-1a) improves muscle strength, exercise capacity, and mitochondrial function in aging mice, reducing sarcopenia markers without extending lifespan. Pharmacological inhibition via PF-5190457 replicates these effects and represents a translatable therapeutic approach.
International patent published for sirtuin 6 muscle therapy
Genflow Biosciences published a patent application for sirtuin 6 variants designed to prevent and treat muscle-mass loss, frailty, and sarcopenia through gene therapy. This approach targets a fundamental mechanism of age-related decline by restoring a protein variant associated with extended lifespan.
Unraveling the role of polyamine metabolism in postoperative delirium: insights into biochemical mechanisms and biomarker potential
Polyamine metabolism dysregulation emerges as a mechanistic contributor to postoperative delirium, with specific metabolites showing potential as predictive biomarkers. This work identifies a biochemical pathway relevant to acute cognitive dysfunction in aging populations and surgical contexts, offering a measurable entry point for intervention.
How an Enzyme’s Depletion Makes Fat Worse
Pck1 enzyme depletion in adipose tissue accelerates cellular senescence and metabolic dysfunction, linking metabolic enzyme loss to accelerated aging in fat cells. This identifies a specific enzymatic mechanism by which declining metabolic capacity in aging tissue drives the accumulation of senescent cells and their inflammatory consequences.
MAK‐2 Kinase Is Required for Extended Longevity and Enhanced Stress Resistance Resulting From Mild Impairment of Mitochondrial Function in isp‐1 Mutants
Mild impairment of mitochondrial function extends lifespan in C. elegans through kinase signaling pathways—particularly MAK-2—that translate mitochondrial stress into nuclear gene expression changes favoring stress resistance and cellular resilience. This demonstrates that longevity benefits from metabolic compromise depend on intact signaling between mitochondria and nucleus, not simply on reduced energy output.
Valine Restriction Extends Male Lifespan 23%
Lifelong dietary valine restriction increased median lifespan in male mice by 23% and maximum lifespan by 15%, while producing modest healthspan improvements in both sexes through mechanisms linked to elevated hepatic mitochondrial activity. The effect was sex-specific, with females showing minimal lifespan extension, pointing to underlying differences in amino acid metabolism between sexes.
Exosome‐Delivered eNAMPT From Exercise Activates SIRT1 to Counteract Age‐Related Hepatic Steatosis and Fibrosis
Exercise triggers release of exosome-delivered eNAMPT, which activates hepatic SIRT1 and autophagy to reverse age-related fatty liver disease, inflammation, and fibrosis in aged mice. This mechanism establishes a biochemical pathway through which physical activity protects metabolic health during aging.
Mitochondrial therapy restores metabolic function without appetite
MitoRx's MTRX31 targets mitochondrial dysfunction rather than appetite suppression, achieving significant fat loss while preserving muscle and metabolic function in preclinical models. This metabolic-first approach addresses a fundamental limitation of current obesity drugs: weight loss achieved through caloric restriction often comes with muscle loss and metabolic compromise.
Zfp462 Is a Key Mediator of Osteoblast Differentiation and Might Contribute to Age‐Related Bone Loss
Zfp462 is a transcriptional regulator essential for osteoblast differentiation and bone formation; aging reduces its expression through altered histone occupancy at its locus, providing a mechanistic explanation for age-related bone loss. Restoring Zfp462 activity or its associated transcriptional machinery represents a potential intervention pathway for senile osteoporosis.
Nuclear senescence precedes neuronal loss in polyglutamine disease
Polyglutamine expansion mutations accelerate nuclear aging pathways independently of neuronal death, revealing that protein misfolding drives cellular senescence before neurons are lost. This finding distinguishes disease mechanisms from cell death, opening intervention points earlier in neurodegeneration progression.
SIRT5 Loss Drives Neuronal Death Through Mitochondrial Fission Dysregulation
SIRT5 downregulation in Alzheimer's disease permits excessive succinylation of HNRNPC, which stabilizes and upregulates YME1L1, disrupting mitochondrial fission-fusion balance and triggering neuronal death. Restoring SIRT5 activity reverses this cascade in mouse models, suggesting a targetable pathway for AD intervention.
FOXM1 activation reverses endothelial aging in atherosclerosis
A platelet membrane-coated resveratrol nanoparticle system activates FOXM1 to restore mitochondrial function and reverse endothelial senescence in atherosclerosis models. The approach addresses both the bioavailability limitations of resveratrol and the cellular dysfunction underlying vascular pathology.